Expression of NKX3.1 in normal and malignant tissues

被引:73
作者
Gelmann, EP
Bowen, C
Bubendorf, L
机构
[1] Georgetown Univ, Sch Med, Lombardi Canc Ctr, Dept Oncol, Washington, DC 20007 USA
[2] Univ Basel, Inst Pathol, Basel, Switzerland
关键词
prostate cancer; breast cancer; lobular carcinoma; prostate specific antigen;
D O I
10.1002/pros.10210
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. NKX3.1, a member of the NK-class of homeodomain proteins, is expressed primarily in the adult prostate and has growth suppression and differentiating effects in prostate epithelial cells. METHODS. We performed immumohistochemical analysis for NKX3.1 and PSA expression in 4,061 samples included in a tissue microarray of a broad spectrum of human cancers and normal tissues. RESULTS. NKX3.1 expression was seen in prostate epithelial cells, prostate cancer, normal testis, 9% of primary and 5% of metastatic infiltrating ductal breast carcinoma, and 27% of primary and 26% of metastatic infiltrating lobular breast carcinoma. In a cohort of 474 primary breast cancers with median follow-up over 62.5 month survival, we found no effect of NKX3.1 expression on prognosis. NKX3.1 expression was more restricted than the spectrum of prostate specific antigen expression. CONCLUSIONS. Expression of NKX3.1 is highly restricted and is found primarily in benign and malignant prostatic epithelial cells and also in normal testis and lobular carcinoma of the breast. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:111 / 117
页数:7
相关论文
共 22 条
[1]   Immunohistochemical labelling for prostate specific antigen in non-prostatic tissues [J].
Alanen, KA ;
Kuopio, T ;
Koskinen, PJ ;
Nevalainen, TJ .
PATHOLOGY RESEARCH AND PRACTICE, 1996, 192 (03) :233-237
[2]   Roles for Nkx3.1 in prostate development and cancer [J].
Bhatia-Gaur, R ;
Donjacour, AA ;
Sciavolino, PJ ;
Kim, M ;
Desai, N ;
Young, P ;
Norton, CR ;
Gridley, T ;
Cardiff, RD ;
Cunha, GR ;
Abate-Shen, C ;
Shen, MM .
GENES & DEVELOPMENT, 1999, 13 (08) :966-977
[3]  
Bowen C, 2000, CANCER RES, V60, P6111
[4]   Tissue microarray (TMA) technology:: miniaturized pathology archives for high-throughput in situ studies [J].
Bubendorf, L ;
Nocito, A ;
Moch, H ;
Sauter, G .
JOURNAL OF PATHOLOGY, 2001, 195 (01) :72-79
[5]   ALLELIC LOSS OF CHROMOSOME-16Q AND CHROMOSOME-10Q IN HUMAN PROSTATE-CANCER [J].
CARTER, BS ;
EWING, CM ;
WARD, WS ;
TREIGER, BF ;
AALDERS, TW ;
SCHALKEN, JA ;
EPSTEIN, JI ;
ISAACS, WB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (22) :8751-8755
[6]  
DOMAGALA W, 1990, AM J PATHOL, V137, P1059
[7]   A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer [J].
He, WW ;
Sciavolino, PJ ;
Wing, J ;
Augustus, M ;
Hudson, P ;
Meissner, PS ;
Curtis, RT ;
Shell, BK ;
Bostwick, DG ;
Tindall, DJ ;
Gelmann, EP ;
AbateShen, C ;
Carter, KC .
GENOMICS, 1997, 43 (01) :69-77
[8]  
Ioachim E, 1996, ANTICANCER RES, V16, P3141
[9]   Expression of α-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase polymerase chain reaction [J].
Ishikawa, T ;
Kashiwagi, H ;
Iwakami, Y ;
Hirai, M ;
Kawamura, T ;
Aiyoshi, Y ;
Yashiro, T ;
Ami, Y ;
Uchida, K ;
Miwa, M .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1998, 28 (12) :723-728
[10]   POINT MUTATION OF THE E-CADHERIN GENE IN INVASIVE LOBULAR CARCINOMA OF THE BREAST [J].
KANAI, Y ;
ODA, T ;
TSUDA, H ;
OCHIAI, A ;
HIROHASHI, S .
JAPANESE JOURNAL OF CANCER RESEARCH, 1994, 85 (10) :1035-1039